- IP to Startups
- Biomedical Research Cores
Bin has 10 years experience in organic synthesis, drug design, discovery and development. His experience includes multiple diseases programs including diabetes, AIDS, cancer, Alzheimer’s disease, Parkinson’s disease and immune-related diseases. Bin obtained his Ph.D. in Medicinal chemistry from Shanghai Institute of Materia Medica, Chinese Academy of Sciences and as a Postdoctoral Fellow at University of Minnesota. Bin is currently working on a program with Mito BioPharm, a Rutgers startup company.